Colorectal Cancers are cancers that begin in the large intestine or rectum. Research has identified numerous germline and somatic mutations in 48 genes that are linked to cancers of the colon and rectum. Next Generation Sequencing (NGS) makes it possible to test the entire exonic regions of all 48 genes. The PrimBio hereditary CRC panel examines germline mutations in genes that may predispose patients to colorectal cancer. This panel covers genes associated with all forms of hereditary colorectal cancer and can help patients and physicians determine if further intervention or action is required based on their results. If detected early, the probability of patient mortality due to the disease is greatly reduced.